169 related articles for article (PubMed ID: 34619758)
1. Association of race and ethnicity with clinical phenotype, genetics, and survival in pediatric acute myeloid leukemia.
Conneely SE; McAtee CL; Gupta R; Lubega J; Scheurer ME; Rau RE
Blood Adv; 2021 Dec; 5(23):4992-5001. PubMed ID: 34619758
[TBL] [Abstract][Full Text] [Related]
2. How do differences in treatment impact racial and ethnic disparities in acute myeloid leukemia?
Patel MI; Ma Y; Mitchell B; Rhoads KF
Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):344-9. PubMed ID: 25662426
[TBL] [Abstract][Full Text] [Related]
3. Age and genetics: how do prognostic factors at diagnosis explain disparities in acute myeloid leukemia?
Patel MI; Ma Y; Mitchell BS; Rhoads KF
Am J Clin Oncol; 2015 Apr; 38(2):159-64. PubMed ID: 23608826
[TBL] [Abstract][Full Text] [Related]
4. Mutational landscape and clinical outcome of pediatric acute myeloid leukemia with 11q23/KMT2A rearrangements.
Yuen KY; Liu Y; Zhou YZ; Wang Y; Zhou DH; Fang JP; Xu LH
Cancer Med; 2023 Jan; 12(2):1418-1430. PubMed ID: 35833755
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors of childhood and adolescent acute myeloid leukemia (AML) survival: evidence from four decades of US population data.
Hossain MJ; Xie L; Caywood EH
Cancer Epidemiol; 2015 Oct; 39(5):720-6. PubMed ID: 26159683
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics, Race, and Treatment Outcome in Pediatric Acute Myeloid Leukemia.
Lamba JK; Marrero R; Wu H; Cao X; Parcha PK; Karol SE; Inaba H; Kuo DJ; Degar BA; Heym K; Taub JW; Lacayo NJ; Pui CH; Ribeiro RC; Pounds SB; Rubnitz JE
JAMA Netw Open; 2024 May; 7(5):e2411726. PubMed ID: 38753328
[TBL] [Abstract][Full Text] [Related]
7. Effects of poverty and race on outcomes in acute myeloid leukemia.
Byrne MM; Halman LJ; Koniaris LG; Cassileth PA; Rosenblatt JD; Cheung MC
Am J Clin Oncol; 2011 Jun; 34(3):297-304. PubMed ID: 20562587
[TBL] [Abstract][Full Text] [Related]
8. Sex disparity in childhood and young adult acute myeloid leukemia (AML) survival: Evidence from US population data.
Hossain MJ; Xie L
Cancer Epidemiol; 2015 Dec; 39(6):892-900. PubMed ID: 26520618
[TBL] [Abstract][Full Text] [Related]
9. Structural racism is a mediator of disparities in acute myeloid leukemia outcomes.
Abraham IE; Rauscher GH; Patel AA; Pearse WB; Rajakumar P; Burkart M; Aleem A; Dave A; Bharadwaj S; Paydary K; Acevedo-Mendez M; Goparaju K; Gomez R; Carlson K; Tsai SB; Quigley JG; Galvin JP; Zia M; Larson ML; Berg S; Stock W; Altman JK; Khan I
Blood; 2022 Apr; 139(14):2212-2226. PubMed ID: 35061876
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of the EVI1 gene expression in patients with acute myeloid leukemia: a meta-analysis.
Wu X; Wang H; Deng J; Zheng X; Ling Y; Gong Y
Ann Hematol; 2019 Nov; 98(11):2485-2496. PubMed ID: 31482295
[TBL] [Abstract][Full Text] [Related]
11. Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements.
Issa GC; Zarka J; Sasaki K; Qiao W; Pak D; Ning J; Short NJ; Haddad F; Tang Z; Patel KP; Cuglievan B; Daver N; DiNardo CD; Jabbour E; Kadia T; Borthakur G; Garcia-Manero G; Konopleva M; Andreeff M; Kantarjian HM; Ravandi F
Blood Cancer J; 2021 Sep; 11(9):162. PubMed ID: 34588432
[TBL] [Abstract][Full Text] [Related]
12. Survival of adult AML patients treated with chemotherapy in the U.S. population by age, race and ethnicity, sex, calendar-year period, and AML subgroup, 2001-2019.
Linet MS; Curtis RE; Schonfeld SJ; Vo JB; Morton LM; Dores GM
EClinicalMedicine; 2024 May; 71():102549. PubMed ID: 38524920
[TBL] [Abstract][Full Text] [Related]
13. The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: a systematic-review and meta-analysis.
Wang R; Gao X; Yu L
BMC Cancer; 2019 Apr; 19(1):389. PubMed ID: 31023266
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of adding gemtuzumab ozogamicin to conventional chemotherapy for adult acute myeloid leukemia: a systematic review and meta-analysis.
Guo Y; Deng L; Qiao Y; Liu B
Hematology; 2022 Dec; 27(1):53-64. PubMed ID: 34957930
[No Abstract] [Full Text] [Related]
15. Effect of race on outcome of white and black children with acute myeloid leukemia: the St. Jude experience.
Rubnitz JE; Lensing S; Razzouk BI; Pounds S; Pui CH; Ribeiro RC
Pediatr Blood Cancer; 2007 Jan; 48(1):10-5. PubMed ID: 16642489
[TBL] [Abstract][Full Text] [Related]
16. Myeloid sarcoma is associated with poor clinical outcome in pediatric patients with acute myeloid leukemia.
Xu LH; Wang Y; Chen ZY; Fang JP
J Cancer Res Clin Oncol; 2020 Apr; 146(4):1011-1020. PubMed ID: 31919567
[TBL] [Abstract][Full Text] [Related]
17. Racial and ethnic disparities in Acute Myeloid Leukemia: 15-year experience at a safety net hospital system.
Dong S; Premnath N; Sadeghi N; Kainthla R; Chung SS; Collins RH; Li HC; Madanat YF
Leuk Res; 2024 Jun; 141():107503. PubMed ID: 38676993
[TBL] [Abstract][Full Text] [Related]
18. Early mortality in acute myeloid leukemia with KMT2A rearrangement is associated with high risk of bleeding and disseminated intravascular coagulation.
Nguyen D; Kantarjian HM; Short NJ; Qiao W; Ning J; Cuglievan B; Daver NG; DiNardo CD; Jabbour EJ; Kadia TM; Borthakur G; Garcia-Manero G; Konopleva MY; Andreeff M; Ravandi-Kashani F; Sasaki K; Issa GC
Cancer; 2023 Jun; 129(12):1856-1865. PubMed ID: 36892949
[TBL] [Abstract][Full Text] [Related]
19. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.
Gröschel S; Lugthart S; Schlenk RF; Valk PJ; Eiwen K; Goudswaard C; van Putten WJ; Kayser S; Verdonck LF; Lübbert M; Ossenkoppele GJ; Germing U; Schmidt-Wolf I; Schlegelberger B; Krauter J; Ganser A; Döhner H; Löwenberg B; Döhner K; Delwel R
J Clin Oncol; 2010 Apr; 28(12):2101-7. PubMed ID: 20308656
[TBL] [Abstract][Full Text] [Related]
20. High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML.
Larkin KT; Nicolet D; Kelly BJ; Mrózek K; LaHaye S; Miller KE; Wijeratne S; Wheeler G; Kohlschmidt J; Blachly JS; Mims AS; Walker CJ; Oakes CC; Orwick S; Boateng I; Buss J; Heyrosa A; Desai H; Carroll AJ; Blum W; Powell BL; Kolitz JE; Moore JO; Mayer RJ; Larson RA; Stone RM; Paskett ED; Byrd JC; Mardis ER; Eisfeld AK
Blood Adv; 2022 Oct; 6(19):5570-5581. PubMed ID: 35788257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
